EA201691792A1 - Фармацевтические составы на основе вилдаглиптина - Google Patents
Фармацевтические составы на основе вилдаглиптинаInfo
- Publication number
- EA201691792A1 EA201691792A1 EA201691792A EA201691792A EA201691792A1 EA 201691792 A1 EA201691792 A1 EA 201691792A1 EA 201691792 A EA201691792 A EA 201691792A EA 201691792 A EA201691792 A EA 201691792A EA 201691792 A1 EA201691792 A1 EA 201691792A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- vildagliptina
- pharmaceutical compositions
- compositions based
- vildagliptin
- diluent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Настоящее изобретение относится к фармацевтическому составу, содержащему фармацевтически эффективное количество вилдаглиптина или его фармацевтически приемлемой соли и разбавитель. В частности, отношение вилдаглиптина к разбавителю находится в диапазоне от 0,04 до 0,24 (вес./вес.).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2014/02685A TR201402685A1 (tr) | 2014-03-06 | 2014-03-06 | Vildagliptinin farmasotik formulasyonları. |
PCT/EP2015/054631 WO2015132341A1 (en) | 2014-03-06 | 2015-03-05 | Pharmaceutical formulations of vildagliptin |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201691792A1 true EA201691792A1 (ru) | 2016-12-30 |
EA030758B1 EA030758B1 (ru) | 2018-09-28 |
Family
ID=52706141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201691792A EA030758B1 (ru) | 2014-03-06 | 2015-03-05 | Фармацевтические составы на основе вилдаглиптина |
Country Status (6)
Country | Link |
---|---|
US (1) | US9795592B2 (ru) |
EP (1) | EP2915527A1 (ru) |
EA (1) | EA030758B1 (ru) |
GE (1) | GEP20196977B (ru) |
TR (1) | TR201402685A1 (ru) |
WO (1) | WO2015132341A1 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111801140A (zh) | 2018-01-17 | 2020-10-20 | 康涅狄格大学 | 治疗糖尿病、肝炎和/或炎症性肝病的方法 |
JP2019182756A (ja) * | 2018-04-03 | 2019-10-24 | 大原薬品工業株式会社 | ビルダグリプチンを含有する固形製剤 |
CN116509844A (zh) * | 2019-12-31 | 2023-08-01 | 石药集团中奇制药技术(石家庄)有限公司 | 一种二肽基肽酶4抑制剂的药物组合物及其制备方法和应用 |
CN111821271A (zh) * | 2020-08-26 | 2020-10-27 | 杭州新诺华医药有限公司 | 维格列汀组合物及其制备方法 |
CN115308325B (zh) * | 2022-08-03 | 2023-07-28 | 海南通用三洋药业有限公司 | 一种维格列汀的残留溶剂检测方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1715893E (pt) * | 2004-01-20 | 2009-10-20 | Novartis Pharma Ag | Formulação para compressão directa e processos |
GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
EA034049B1 (ru) * | 2009-07-31 | 2019-12-23 | КРКА, д.д., НОВО МЕСТО | Гранулят, включающий вилдаглиптин, способ его получения и фармацевтическая композиция |
IN2012DN03271A (ru) * | 2009-10-23 | 2015-10-23 | Merck Sharp & Dohme | |
PL2578208T3 (pl) * | 2011-10-06 | 2014-10-31 | Sanovel Ilac Sanayi Ve Ticaret As | Stałe formulacje dawkowane inhibitora DPP-IV |
US20140248345A1 (en) | 2011-10-24 | 2014-09-04 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with atorvastatin |
-
2014
- 2014-03-06 TR TR2014/02685A patent/TR201402685A1/tr unknown
-
2015
- 2015-03-05 EA EA201691792A patent/EA030758B1/ru not_active IP Right Cessation
- 2015-03-05 EP EP15157759.0A patent/EP2915527A1/en not_active Withdrawn
- 2015-03-05 WO PCT/EP2015/054631 patent/WO2015132341A1/en active Application Filing
- 2015-03-05 US US15/123,818 patent/US9795592B2/en not_active Expired - Fee Related
- 2015-03-05 GE GEAP201514292A patent/GEP20196977B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2915527A1 (en) | 2015-09-09 |
EA030758B1 (ru) | 2018-09-28 |
WO2015132341A1 (en) | 2015-09-11 |
TR201402685A1 (tr) | 2015-09-21 |
GEP20196977B (en) | 2019-06-10 |
US20170014379A1 (en) | 2017-01-19 |
US9795592B2 (en) | 2017-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
MX2018001990A (es) | Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac. | |
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
MX2018002986A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos. | |
EA201691726A1 (ru) | Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
NZ739676A (en) | Heteroaryl compounds as irak inhibitors and uses thereof | |
EA201691134A1 (ru) | Новые ингибиторы глутаминазы | |
PH12017502051A1 (en) | TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF | |
EA201890858A1 (ru) | 2,4-дигидроксиникотинамиды как агонисты apj | |
WO2016044463A3 (en) | Mk2 inhibitors and uses thereof | |
EA201791896A1 (ru) | Дезацетокситубулизин н и его аналоги | |
EA201692548A1 (ru) | Минеральные аминокислотные комплексы активных веществ | |
CL2015002897A1 (es) | Inhibidores de bace1 | |
EA201791174A1 (ru) | Антимикотическое соединение | |
EA201691792A1 (ru) | Фармацевтические составы на основе вилдаглиптина | |
EA201791992A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
EA201890364A1 (ru) | СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t | |
EA201892822A1 (ru) | Новые антибактериальные соединения | |
EA201791009A1 (ru) | Композиции, содержащие циклоспорин | |
EA201792262A1 (ru) | Пироглутамат вортиоксетина | |
EA201792000A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
IN2014CH00840A (ru) | ||
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
EA201692569A1 (ru) | Полимиксины с низкой степенью замещения и композиции, их содержащие |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |